Quanterix: Still Many Questions After An Eventful 2025 (NASDAQ:QTRX)

If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!In May of last year, I concluded that it was difficult to make the right diagnosis on shares of Quanterix ( QTRX ). This followed its acquisition of Akoya Biosciences, a deal that added losses and ...